CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel‐induced cytotoxicity

Abstract

These results support a mechanism of chemotherapy resistance mediated by cellular stress responses involving the induction of CCL2 expression and suggest that inhibiting CCL2 activity could enhance therapeutic responses to taxane-based therapy.